Post-Approval Changes to Packaging Materials: What Triggers a Filing
By the Green Medical Packing engineering team

A packaging material can keep the same product name, the same supplier and the same certificate while the film inside the carton is no longer the material that was filed. That gap is what change control exists to close, and it is where most packaging compliance problems start.
Why a packaging change is easy to underestimate
Packaging is usually filed as part of the drug product, not as a separate entity. The material in the dossier is described by specification: polymer, gauge, coating weight, additives, supplier and manufacturing site. When any of those moves, the pack may still look identical on the line while the filed description no longer matches what is being bought.
Three situations account for most of the confusion:
- The supplier changes a raw material source and issues a new datasheet with the same trade name.
- The converter moves production to another line or site, with the same specification on paper.
- The buyer accepts a wider gauge tolerance to improve yield, without revisiting the filed range.
Each of these can be handled. The problem is handling them after the batch has shipped.
Three treatment levels, and who decides
Regulators generally treat packaging changes along a spectrum, and the market decides which band applies:
1. No notification. Changes that stay inside the filed specification and do not affect the material's performance or the product's stability profile. A new roll core diameter is the usual example. 2. Notification after implementation. Changes that are documented and reported in the next annual report or variation cycle, supported by comparability data. 3. Prior approval. Changes that alter the material's composition or the packaging system's performance: a different polymer, a new coating, a change of manufacturing site for a critical component.
The exact allocation differs between the US, the EU, China and other markets, and it has moved in recent years. The supplier can document what changed; only the marketing authorisation holder can decide what that means for a filing. Treat any statement that a change is "not reportable" as a question for the regulatory lead, not as a supplier conclusion.
What documentation makes a change defensible
A change is defensible when the buyer can show that the material before and after are equivalent for the intended use. That usually needs four things:
- A specification comparison listing every parameter that moved, with old and new values, not a summary that says "minor change".
- Batch data before and after, ideally three batches each, on the parameters that matter for the pack: gauge profile, coating weight, seal strength, WVTR.
- A stability statement, either new data or a justified technical rationale when the pack's barrier is unchanged.
- An extractables assessment when the change touches composition, additives or a coating, because that is where patient exposure questions arise.
Where the change is a site move, add the quality system evidence for the new site: current ISO 15378 certificate, audit history and the change-control procedure that governs the transfer.
The supplier-side triggers buyers should ask about
Most surprises come from changes the supplier considered internal. A buyer who asks about them at qualification avoids the argument later:
- Resin or polymer grade substitution, including a switch between suppliers of the same grade.
- Additive package changes: slip agents, stabilisers, antiblock, colorants.
- Coating weight or lacquer chemistry on coated films and lidding foil.
- Extrusion or coating line changes, including new screws, new dryers or a rebuilt coating head.
- Slitting, winding and core changes that alter the roll's behaviour on a high-speed line.
- Print process changes: ink system, cylinder re-engraving, lamination adhesive.
- Site changes for any step, including subcontract slitting.
A supplier with a working change-control system can answer these with dated notifications. A supplier without one answers them only when asked, which is the same as answering them late.
A change-control checklist
| Step | What to confirm | Evidence to keep |
|---|---|---|
| Classify | Which regulatory band the change falls into | Written regulatory assessment |
| Compare | Every specification parameter affected | Old and new datasheets side by side |
| Verify | Performance on the parameters that matter | Batch data, seal and barrier results |
| Justify | Why the pack remains suitable | Stability rationale or new data |
| Approve | Who signs, and against which procedure | Signed change record |
| Review | Whether the filed description still matches | Updated dossier reference |
Two practical rules make this work. First, keep the approved specification as the single source of truth, so a drift in gauge tolerance or coating weight is visible before it becomes a batch. Second, agree notification timing in the supply agreement: how many days before implementation, and through which contact.
Choosing a supplier who documents change
Ask for the change-control procedure itself, not a promise to notify. Then ask for one real notification example with dates, redacted as needed. A supplier that can produce both has a system; a supplier that cannot may still be reliable, but you will be the one rebuilding the paper trail when something moves.
For the wider qualification picture, our supplier audit checklist covers the evidence to request before the first order, and the compendial requirements comparison explains how USP, EP, JP and the Chinese Pharmacopoeia treat the same material differently. Our procurement reference sets out the specification items and documents we issue with each batch of high-barrier film.
Materials supplied by Green Medical Packing are produced under ISO 15378 and GMP, with batch certificates of analysis and change notification written into the supply agreement.
Have questions about this topic?
Send your pack format and target market — our technical team replies within 48 hours.
Recommended materials
Materials referenced in this article

Tropical Aluminum
Ultra-high barrier aluminum laminate for tropical and high-humidity pharmaceutical markets
View specifications
High-Barrier PVC Films
Advanced moisture and oxygen barrier for extended shelf life
View specifications
PVC/APET Laminated Rigid Sheet
Composite PVC/APET rigid sheet combining forming performance with a high-gloss print surface
View specifications

